99 related articles for article (PubMed ID: 1450185)
1. Matching clinical and biological specificity: implications for biological psychiatry.
Pivik RT
J Psychiatry Neurosci; 1992 Oct; 17(4):132. PubMed ID: 1450185
[No Abstract] [Full Text] [Related]
2. Dopamine receptor genes: new tools for molecular psychiatry.
Niznik HB; Van Tol HH
J Psychiatry Neurosci; 1992 Oct; 17(4):158-80. PubMed ID: 1450188
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia: D4 receptor elevation. What does it mean?
Seeman MV
J Psychiatry Neurosci; 1994 May; 19(3):171-6. PubMed ID: 7913338
[No Abstract] [Full Text] [Related]
4. Association study between dopamine D1, D2, D3, and D4 receptor genes and schizophrenia defined by several diagnostic systems.
Dollfus S; Campion D; Vasse T; Preterre P; Laurent C; d'Amato T; Thibaut F; Mallet J; Petit M
Biol Psychiatry; 1996 Sep; 40(5):419-21. PubMed ID: 8874845
[No Abstract] [Full Text] [Related]
5. [Molecular genetics of cognitive deficit in schizophrenia].
Golimbet VE
Mol Biol (Mosk); 2008; 42(5):830-9. PubMed ID: 18988532
[TBL] [Abstract][Full Text] [Related]
6. Schizophrenia and DA-hypothesis: pathological and therapeutic aspects. 9th annual meeting of the Belgian College of Neuropsychopharmacological and Biological Psychiatry. Louvain-en-Woluwe, 21 November 1986. Proceedings.
Acta Psychiatr Belg; 1987; 87(5):521-617. PubMed ID: 3451673
[No Abstract] [Full Text] [Related]
7. Role of glucocorticoids in dopamine-related neuropsychiatric disorders.
Van Craenenbroeck K; De Bosscher K; Vanden Berghe W; Vanhoenacker P; Haegeman G
Mol Cell Endocrinol; 2005 Dec; 245(1-2):10-22. PubMed ID: 16310935
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of schizophrenia: a review.
Sigmundson HK
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptors and the dopamine hypothesis of schizophrenia.
Seeman P
Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
[TBL] [Abstract][Full Text] [Related]
10. [Neuroendocrinology and schizophrenia research].
Müller-Spahn F
Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1991; 64():1-96. PubMed ID: 1682802
[No Abstract] [Full Text] [Related]
11. Schizophrenia: into the next millennium.
Jones B
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S67-9. PubMed ID: 7902776
[TBL] [Abstract][Full Text] [Related]
12. Dopamine and schizophrenia.
Ashby B
Nature; 1990 Dec; 348(6301):493. PubMed ID: 2174127
[No Abstract] [Full Text] [Related]
13. [Neuroleptics and nicotine].
Erdmann R
Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptors and schizophrenia.
Reynolds GP
Biochem Soc Trans; 1996 Feb; 24(1):202-5. PubMed ID: 8674664
[No Abstract] [Full Text] [Related]
15. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
Wiesel FA
Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
[TBL] [Abstract][Full Text] [Related]
16. The effects of clozapine on neurocognition: an overview.
Goldberg TE; Weinberger DR
J Clin Psychiatry; 1994 Sep; 55 Suppl B():88-90. PubMed ID: 7525543
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between genetic polymorphism of dopamine receptor and schizophrenia and its forensic significance].
Yao J; Wang BJ
Fa Yi Xue Za Zhi; 2014 Jun; 30(3):202-6. PubMed ID: 25272877
[TBL] [Abstract][Full Text] [Related]
18. Left striato-pallidal hyperactivity in schizophrenia. Part II: Phenomenology and thought disorder.
Early TS; Posner MI; Reiman EM; Raichle ME
Psychiatr Dev; 1989; 7(2):109-21. PubMed ID: 2695922
[TBL] [Abstract][Full Text] [Related]
19. Evidence for reduced and dysregulated turnover of dopamine in schizophrenia.
Heritch AJ
Schizophr Bull; 1990; 16(4):605-15. PubMed ID: 2077638
[TBL] [Abstract][Full Text] [Related]
20. [Dopaminergic receptor activity and the evolution of schizophrenia].
Fodoreanu L
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(2):131-4. PubMed ID: 2864729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
